Loading chat...

HI SR4

Resolution

Status

Introduced

1/30/2025

Primary Sponsor

Kurt Fevella

Click for details

Origin

Senate

2025 Regular Session

AI Summary

SR4 Summary

  • Requests the State Auditor to assess the social and financial effects of a proposed mandate requiring health insurance coverage for intravenous ketamine therapy to treat depression

  • Requires the assessment to be conducted pursuant to Hawaii Revised Statutes section 23-51, which mandates auditor review before any health insurance mandate can be considered legislatively

  • Auditor must submit findings, recommendations, and any proposed legislation to the Legislature no later than twenty days before the 2026 Regular Session convenes

  • Certified copies of the resolution must be transmitted to the Auditor and Insurance Commissioner

Legislative Description

Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Intravenous Ketamine Therapy To Treat Depression.

Medicaid

Last Action

The committee on HHS deferred the measure.

3/24/2025

Committee Referrals

Health and Human Services2/3/2025

Full Bill Text

No bill text available